Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313506872> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W4313506872 endingPage "38" @default.
- W4313506872 startingPage "30" @default.
- W4313506872 abstract "Purpose of this study was to determine the prevalence of antimicrobial resistance in microbial pathogens from different clinical samples. The current study was conducted in Lahore, Faisalabad,Rawalpindi and Islamabad as these cities are ranked as highly populated cities of Pakistan. Isolation and identification of pathogens from almost 750 diverse urine, blood and pus samples by aid of selected media cultures, gram staining and various biochemical tests. Isolated pathogens were checked for antimicrobial susceptibility patterns against frequently prescribed antibiotics. In present study, Gram-negative isolates were found in maximum percentages (80 Percent) while the remaining (20 Percent) were Gram-positives. The isolate which was most recurrently recognized from Gram-positives was S. aureus and most frequently identified isolate from Gram-negative was E. coli and P. aeruginosa. The prevalence of E. coli was 20 Percent in urine, 14Percentin blood, 12Percent in stool and 4 Percent in pus. Furthermore, the resistance rate of E. coli for Streptomycin, Nalidixicacid, Ciprofloxacin, Levofloxacin, Doxycycline, Moxifloxacin, Amikacin, Gentamycin, and Amoxicillin werebetween 12 Percent to a maximum of 100Percent. Gram positive S. aureus was found considerable in urine (9Percent), bloodand pus cultures. The resistance shown by the isolates ranged from 12Percent to 100Percent against ceftriaxone,ampicillin, chloramphenicol, doxycycline, co-trimoxazole, penicillin, erythromycin, vancomycin and tetracycline. Moreover, the antibiotics like Augmentin (71Percent) and Moxifloxacin (60Percent) showed highest resistance so these are considered as poor choices for treating S. aureus infections. We concluded from this study that strict legislation and better management techniques in context to use of antimicrobial for therapeutic purposes in human and animals can minimize the chances of development of antimicrobial resistance." @default.
- W4313506872 created "2023-01-06" @default.
- W4313506872 creator A5047241639 @default.
- W4313506872 creator A5058445352 @default.
- W4313506872 creator A5069993771 @default.
- W4313506872 creator A5073583022 @default.
- W4313506872 creator A5086046413 @default.
- W4313506872 date "2021-12-30" @default.
- W4313506872 modified "2023-09-27" @default.
- W4313506872 title "Study of Trends of Antimicrobial Resistance in Clinical Bacterial Isolates from Three Private Tertiary Healthcare Facility in Pakistan" @default.
- W4313506872 doi "https://doi.org/10.31703/gdddr.2021(vi-iv).03" @default.
- W4313506872 hasPublicationYear "2021" @default.
- W4313506872 type Work @default.
- W4313506872 citedByCount "0" @default.
- W4313506872 crossrefType "journal-article" @default.
- W4313506872 hasAuthorship W4313506872A5047241639 @default.
- W4313506872 hasAuthorship W4313506872A5058445352 @default.
- W4313506872 hasAuthorship W4313506872A5069993771 @default.
- W4313506872 hasAuthorship W4313506872A5073583022 @default.
- W4313506872 hasAuthorship W4313506872A5086046413 @default.
- W4313506872 hasBestOaLocation W43135068721 @default.
- W4313506872 hasConcept C174802600 @default.
- W4313506872 hasConcept C2776021129 @default.
- W4313506872 hasConcept C2777427914 @default.
- W4313506872 hasConcept C2778512257 @default.
- W4313506872 hasConcept C2778836808 @default.
- W4313506872 hasConcept C2778980435 @default.
- W4313506872 hasConcept C2779489039 @default.
- W4313506872 hasConcept C2779708577 @default.
- W4313506872 hasConcept C2781276175 @default.
- W4313506872 hasConcept C4937899 @default.
- W4313506872 hasConcept C501593827 @default.
- W4313506872 hasConcept C523546767 @default.
- W4313506872 hasConcept C54355233 @default.
- W4313506872 hasConcept C71924100 @default.
- W4313506872 hasConcept C86803240 @default.
- W4313506872 hasConcept C89423630 @default.
- W4313506872 hasConcept C94665300 @default.
- W4313506872 hasConceptScore W4313506872C174802600 @default.
- W4313506872 hasConceptScore W4313506872C2776021129 @default.
- W4313506872 hasConceptScore W4313506872C2777427914 @default.
- W4313506872 hasConceptScore W4313506872C2778512257 @default.
- W4313506872 hasConceptScore W4313506872C2778836808 @default.
- W4313506872 hasConceptScore W4313506872C2778980435 @default.
- W4313506872 hasConceptScore W4313506872C2779489039 @default.
- W4313506872 hasConceptScore W4313506872C2779708577 @default.
- W4313506872 hasConceptScore W4313506872C2781276175 @default.
- W4313506872 hasConceptScore W4313506872C4937899 @default.
- W4313506872 hasConceptScore W4313506872C501593827 @default.
- W4313506872 hasConceptScore W4313506872C523546767 @default.
- W4313506872 hasConceptScore W4313506872C54355233 @default.
- W4313506872 hasConceptScore W4313506872C71924100 @default.
- W4313506872 hasConceptScore W4313506872C86803240 @default.
- W4313506872 hasConceptScore W4313506872C89423630 @default.
- W4313506872 hasConceptScore W4313506872C94665300 @default.
- W4313506872 hasIssue "IV" @default.
- W4313506872 hasLocation W43135068721 @default.
- W4313506872 hasOpenAccess W4313506872 @default.
- W4313506872 hasPrimaryLocation W43135068721 @default.
- W4313506872 hasRelatedWork W2018507991 @default.
- W4313506872 hasRelatedWork W2059780464 @default.
- W4313506872 hasRelatedWork W2166194120 @default.
- W4313506872 hasRelatedWork W2213180199 @default.
- W4313506872 hasRelatedWork W2298161860 @default.
- W4313506872 hasRelatedWork W2461645720 @default.
- W4313506872 hasRelatedWork W2545527470 @default.
- W4313506872 hasRelatedWork W2742964839 @default.
- W4313506872 hasRelatedWork W4253170182 @default.
- W4313506872 hasRelatedWork W753526584 @default.
- W4313506872 hasVolume "VI" @default.
- W4313506872 isParatext "false" @default.
- W4313506872 isRetracted "false" @default.
- W4313506872 workType "article" @default.